Patents Represented by Attorney, Agent or Law Firm James Harrington
  • Patent number: 6825172
    Abstract: 3-Descladinosyl-6-O-carbamoyl and 6-O-carbonoyl macrolide antibacterial agents of the formula: wherein R1, W, R3, R4, R5, R6, X, X′, and Z are as described herein and in which the substituents have the meaning indicated in the description. These compounds are useful as antibacterial agents.
    Type: Grant
    Filed: May 28, 2003
    Date of Patent: November 30, 2004
    Assignee: Janssen Pharmaceutica, NV
    Inventors: Todd C. Henninger, Mark J. Macielag, Brett A. Marinelli, Bin Zhu
  • Patent number: 6432296
    Abstract: Improved dry-operative ion-selective electrodes and their use are described. The dry-operative ion-selective electrodes include an internal reference electrode comprising a water-soluble salt dispersed in a polymer binder consisting essentially of a monomer having at least one carboxyl group and a hydrophobic monomer. The polymer provides reduced brittleness, good interlayer adhesion and high salt tolerance.
    Type: Grant
    Filed: August 30, 2000
    Date of Patent: August 13, 2002
    Inventors: Daniel S. Daniel, Richard L. Detwiler, Andrew M. Kirsch, James E. Love, Jr., Richard C. Sutton
  • Patent number: 6322992
    Abstract: An analytical element can be used to sensitively and rapidly detect a wide variety of specific binding ligands in either a competitive or sandwich assay format. The assays are carried out using a vanadium bromoperoxidase-labeled immunoreactant and a chemiluminescent signal-providing wash composition which comprises a 2,3-dihydro-1,4-phthalazinedione derivative; a halogen, pseudohalogen, halogen-providing source or pseudohalogen-providing source; and a peroxide or a peroxide-generating reagent composition.
    Type: Grant
    Filed: October 17, 1997
    Date of Patent: November 27, 2001
    Assignee: Johnson & Johnson Clinical Diagnostics, Inc.
    Inventors: Alan Eric Friedman, Thomas Robert Kissel, Sarah Fingar Groulx, Martha Miller Kopcienski
  • Patent number: 6309661
    Abstract: Solid, bioabsorbable materials for use as wound dressings comprise at least 50% by weight of a mixture of xanthan and at least one galactomannan, such as guar gum or locust bean gum. The weight ratio of xanthan: total galactomannans is in the range 1:99 to 99:1, preferably 10:99 to 99:10. The material is preferably made in the form of a sponge by freeze drying a mixed aqueous gel of the xanthan and galactomannans.
    Type: Grant
    Filed: February 27, 1998
    Date of Patent: October 30, 2001
    Inventors: Carla A. Haynes, Elaine Lorimer
  • Patent number: 6046052
    Abstract: A dry analytical element is disclosed which can be used to sensitively and rapidly detect and quantitate protein. The assays are carried out using a dye that reacts with protein and molybdate ion to produce a measurable change in the spectral absorption of the dye. Also disclosed are polymers which stabilize and enhance the accuracy of the assay, and compounds which reduce interference by bicarbonate.
    Type: Grant
    Filed: April 24, 1998
    Date of Patent: April 4, 2000
    Assignee: Ortho Clinical Diagnostics, Inc.
    Inventors: Thomas Arter, David B. LaTart, John C. Mauck, Richard C. Sutton, Wayne Weber, Robert Winterkorn, James Schaeffer
  • Patent number: 5874428
    Abstract: The present invention relates to novel N-substituted azaheterocyclic carboxylic acids and esters thereof in which a substituted alkyl chain forms part of the N-substituent or salts thereof, to methods for their preparation, to compositions containing them, and to their use for the clinical treatment of painful, hyperalgesic and/or inflammatory conditions in which C-fibers play a pathophysiological role by eliciting neurogenic pain or inflammation.
    Type: Grant
    Filed: March 28, 1996
    Date of Patent: February 23, 1999
    Assignee: Novo Nordisk Als
    Inventors: Florenzio Zaragossa D.o slashed.rwald, Knud Erik Andersen, Rolf Hohlweg, Peter Madsen, Tine Krogh J.o slashed.rgensen, Uffe Bang Olsen, Henrik Sune Andersen, Svend Treppendahl, Polivka Zdenek, Silhankova Alexandra, Sindelar Karel
  • Patent number: 5874558
    Abstract: A process for expression of a protein product in Aspergillus oryzae is disclosed. The process comprises transforming Aspergillus oryzae with a vector system comprising DNA-sequences encoding functions facilitating gene expression, a suitable marker for selection of transformants, and a DNA-sequence encoding the desired protein product. The process enables industrial production of many different polypeptides and proteins in A. oryzae. Examples of such products are chymosin or prochymosin and other rennets, proteases, lipases and amylases. Also disclosed is an effective promoter for expression of a protein in Aspergillus. A preferred promoter is the TAKA-amylase promoter or functional parts thereof. There is also provided a process for the production of a recombinant Humicola lipase. The recombinant Humicola lipase from A. oryzae differs from the native lipase in having a greater glycosylation and in exhibiting an improved thermostability.
    Type: Grant
    Filed: May 17, 1996
    Date of Patent: February 23, 1999
    Assignee: Novo Nordisk
    Inventors: Esper Boel, Tove Christensen, Helle Fabricius Woldike
  • Patent number: 5830736
    Abstract: The present invention relates to novel lipolytic enzymes. More specifically the invention provides novel lipolytic enzymes having the properties of a lipase native to the strain Fusarium culmorum CBS 513.94, or has immunochemical properties identical or partially identical to those of a lipase native to the strain Fusarium culmorum CBS 513.94.
    Type: Grant
    Filed: April 4, 1997
    Date of Patent: November 3, 1998
    Assignee: Novo Nordisk A/S
    Inventors: Karen Margrethe Oxenb.o slashed.ll, Kim Borch, Shamkant Anant Patkar